Cargando…
Inhibitory effect of lovastatin on human lung cancer cell proliferation by regulating the ERK1/2 and COX-2 pathways
BACKGROUND: Lovastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase, effectively inhibiting cholesterol synthesis. Previous research findings showed that lovastatin markedly suppressed tumor cell proliferation and metastasis and induced apoptosis. The present study aimed to determine...
Autores principales: | Liu, Sha, Yang, Ping, Wang, Mingkung, Zhang, Shuang, Wang, Jie, Pan, Tao, Zhou, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091021/ https://www.ncbi.nlm.nih.gov/pubmed/35571660 http://dx.doi.org/10.21037/tcr-22-346 |
Ejemplares similares
-
Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2/PPARγ-dependent pathway
por: Walther, Udo, et al.
Publicado: (2016) -
Efficacy of Lovastatin on Learning and Memory Deficits Caused by Chronic Intermittent Hypoxia-Hypercapnia: Through Regulation of NR2B-Containing NMDA Receptor-ERK Pathway
por: Huo, Xin-long, et al.
Publicado: (2014) -
Lovastatin inhibits erythroleukemia progression through KLF2-mediated suppression of MAPK/ERK signaling
por: Gao, Jian, et al.
Publicado: (2023) -
HER2 induces cell proliferation and invasion of non-small-cell lung cancer by upregulating COX-2 expression via MEK/ERK signaling pathway
por: Chi, Feng, et al.
Publicado: (2016) -
Analgesic effects of the COX-2 inhibitor parecoxib on surgical pain through suppression of spinal ERK signaling
por: GUO, YA-JING, et al.
Publicado: (2013)